ALX Oncology (ALXO) Stock Forecast & Price Target $0.61 -0.01 (-1.77%) Closing price 04/1/2025 04:00 PM EasternExtended Trading$0.62 +0.01 (+1.63%) As of 04/1/2025 07:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ALX Oncology - Analysts' Recommendations and Stock Price Forecast (2025) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating Moderate BuyBased on 7 Analyst RatingsSell0Hold2Buy5 Based on 7 Wall Street analysts who have issued ratings for ALX Oncology in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 7 analysts, 2 have given a hold rating, and 5 have given a buy rating for ALXO. Consensus Price Target $4.14576.47% Upside According to the 7 analysts' twelve-month price targets for ALX Oncology, the average price target is $4.14. The highest price target for ALXO is $9.00, while the lowest price target for ALXO is $1.50. The average price target represents a forecasted upside of 576.47% from the current price of $0.61. Get the Latest News and Ratings for ALXO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for ALX Oncology and its competitors. Enter your email to sign up for newsletter Sign Up ALXO Analyst Ratings Over TimeTypeCurrent Forecast4/2/24 to 4/2/251 Month Ago3/3/24 to 3/3/253 Months Ago1/3/24 to 1/2/251 Year Ago4/3/23 to 4/2/24Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy5 Buy rating(s)3 Buy rating(s)3 Buy rating(s)6 Buy rating(s)Hold2 Hold rating(s)3 Hold rating(s)3 Hold rating(s)1 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$4.14$3.05$8.50$18.42Forecasted Upside576.47% Upside196.12% Upside444.87% Upside71.80% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyModerate Buy Remove Ads ALXO Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History ALXO Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table ALX Oncology Stock vs. The CompetitionTypeALX OncologyMedical CompaniesS&P 500Consensus Rating Score 2.71 2.82 2.54Consensus RatingModerate BuyModerate BuyModerate BuyPredicted Upside576.47% Upside19,837.88% Upside19.03% UpsideNews Sentiment RatingVery Positive NewsSee Recent ALXO NewsPositive NewsPositive News Remove Ads Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails3/7/2025Stifel Nicolaus4 of 5 starsBradley CaninoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetHold ➝ Hold$3.00 ➝ $1.50+39.53%3/7/2025HC Wainwright1 of 5 starsSwayampakula RamakanthSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$5.00 ➝ $5.00+281.68%3/6/2025Piper Sandler2 of 5 starsChristopher RaymondSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetOverweight ➝ Overweight$8.00 ➝ $9.00+628.74%3/6/2025Jefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingMichael YeeSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold ➝ Buy$2.00 ➝ $3.00+188.46%1/27/2025UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingColin BristowSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower TargetBuy ➝ Buy$4.00 ➝ $2.20+50.17%1/24/2025Cantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingLi WatsekSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight7/31/2024Lifesci CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingS. SlutskySubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ HoldAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 01:34 AM ET. ALXO Forecast - Frequently Asked Questions What is ALX Oncology's forecast for 2025? According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for ALX Oncology is $4.14, with a high forecast of $9.00 and a low forecast of $1.50. Should I buy or sell ALX Oncology stock right now? 7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ALX Oncology in the last year. There are currently 2 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" ALXO shares. Does ALX Oncology's stock price have much upside? According to analysts, ALX Oncology's stock has a predicted upside of 576.47% based on their 12-month stock forecasts. Has ALX Oncology been upgraded by Wall Street analysts recently? Over the previous 90 days, ALX Oncology's stock had 1 upgrade by analysts. What analysts cover ALX Oncology? ALX Oncology has been rated by research analysts at Cantor Fitzgerald, HC Wainwright, Jefferies Financial Group, Piper Sandler, Stifel Nicolaus, and UBS Group in the past 90 days. Do Wall Street analysts like ALX Oncology more than its competitors? Analysts like ALX Oncology less than other "medical" companies. The consensus rating score for ALX Oncology is 2.71 while the average consensus rating score for "medical" companies is 2.82. Learn more on how ALXO compares to other companies. Stock Forecasts and Research Tools Related Companies scPharmaceuticals Stock Forecast Actuate Therapeutics Stock Forecast Nkarta Stock Forecast Compugen Stock Forecast Organigram Stock Forecast Greenwich LifeSciences Stock Forecast Journey Medical Stock Forecast Seres Therapeutics Stock Forecast Alector Stock Forecast Enanta Pharmaceuticals Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter This page (NASDAQ:ALXO) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | SponsoredPartner with Elon Musk on Project Colossus… Before May 1stEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALX Oncology Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ALX Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ALXO Stock Free ALXO Stock Alerts